Jefferies has reiterated its buy rating on PB Fintech, setting a target price of Rs 1,800. The company’s management plans a one-time investment of up to $100 million for a 20-35% stake in a new healthcare venture, addressing concerns about maintaining its asset-light strategy. PB Fintech remains a top pick for India’s growing insurance market, with its core business continuing to experience strong growth.
Subscribe To Our Free Newsletter |